Nea Partners 15, L.p. - Net Worth and Insider Trading
Nea Partners 15, L.p. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Nea Partners 15, L.p. owns 20 companies in total, including Eargo Inc (EAR) , Inozyme Pharma Inc (INZY) , and Annexon Inc (ANNX) among others .
Click here to see the complete history of Nea Partners 15, L.p.’s form 4 insider trades.
Insider Ownership Summary of Nea Partners 15, L.p.
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| EAR | Eargo Inc | 2020-10-15 | 10 percent owner |
| INZY | Inozyme Pharma Inc | 2020-07-23 | 10 percent owner |
| ANNX | Annexon Inc | 2020-07-23 | 10 percent owner |
 | | 2020-07-09 | 10 percent owner |
| | 2016-05-13 | 10 percent owner |
| | 2019-06-07 | 10 percent owner |
| | 2018-12-07 | 10 percent owner |
| | 2018-03-09 | 10 percent owner |
| | 2015-06-16 | 10 percent owner |
| | 2016-12-19 | 10 percent owner |
| | 2018-12-07 | 10 percent owner |
| | 2021-04-08 | 10 percent owner |
| | 2021-06-24 | 10 percent owner |
| | 2020-12-09 | 10 percent owner |
| | 2021-07-29 | director & 10 percent owner |
| | 2022-02-03 | 10 percent owner |
| | 2021-07-21 | 10 percent owner |
| | 2021-09-30 | 10 percent owner |
| | 2022-06-08 | 10 percent owner |
| | 2021-07-21 | 10 percent owner |
Nea Partners 15, L.p. Trading Performance
Nea Partners 15, L.p. Ownership Network
Ownership Network List of Nea Partners 15, L.p.
Ownership Network Relation of Nea Partners 15, L.p.
Nea Partners 15, L.p. Owned Company Details
What does Eargo Inc do?
Who are the key executives at Eargo Inc?
Nea Partners 15, L.p. is the 10 percent owner of Eargo Inc. Other key executives at Eargo Inc include Chief Accounting Officer Mark Thorpe , Chief Operating Officer William Brownie , and Chief Financial Officer Adam Laponis .
Eargo Inc (EAR) Insider Trades Summary
Over the past 18 months, Nea Partners 15, L.p. made no insider transaction in Eargo Inc (EAR). Other recent insider transactions involving Eargo Inc (EAR) include a net sale of 1,528 shares made by William Brownie , a net sale of 38 shares made by Adam Laponis , and a net sale of 6 shares made by Mark Thorpe .
In summary, during the past 3 months, insiders sold 0 shares of Eargo Inc (EAR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,630 shares of Eargo Inc (EAR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,630 shares.
Eargo Inc (EAR)'s detailed insider trading history can be found in Insider Trading Tracker table.
Eargo Inc Insider Transactions
- Download to Excel(.xls)
What does Inozyme Pharma Inc do?
Who are the key executives at Inozyme Pharma Inc?
Nea Partners 15, L.p. is the 10 percent owner of Inozyme Pharma Inc. Other key executives at Inozyme Pharma Inc include director & 10 percent owner Robert Lorne Hopfner , COO Matthew Winton , and 10 percent owner Longitude Capital Partners Iii, Llc .
Inozyme Pharma Inc (INZY) Insider Trades Summary
Over the past 18 months, Nea Partners 15, L.p. made no insider transaction in Inozyme Pharma Inc (INZY). Other recent insider transactions involving Inozyme Pharma Inc (INZY) include a net purchase of 1,281,265 shares made by Robert Lorne Hopfner , a net purchase of 833,333 shares made by Pivotal Bioventure Partners Fund I G.p., L.p. , and a net sale of 7,523 shares made by Douglas A Treco .
In summary, during the past 3 months, insiders sold 0 shares of Inozyme Pharma Inc (INZY) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 7,523 shares of Inozyme Pharma Inc (INZY) were sold and 2,114,598 shares were bought by its insiders, resulting in a net purchase of 2,107,075 shares.
Inozyme Pharma Inc (INZY)'s detailed insider trading history can be found in Insider Trading Tracker table.
Inozyme Pharma Inc Insider Transactions
- Download to Excel(.xls)
What does Annexon Inc do?
Who are the key executives at Annexon Inc?
Nea Partners 15, L.p. is the 10 percent owner of Annexon Inc. Other key executives at Annexon Inc include EVP & Chief Innovation Officer Ted Yednock , EVP & Chief Financial Officer Jennifer Lew , and EVP & Chief Business Officer Michael Overdorf .
Annexon Inc (ANNX) Insider Trades Summary
Over the past 18 months, Nea Partners 15, L.p. made no insider transaction in Annexon Inc (ANNX). Other recent insider transactions involving Annexon Inc (ANNX) include a net sale of 74,985 shares made by Ted Yednock , a net purchase of 22,400 shares made by William H. Carson , and a net sale of 6,563 shares made by Jennifer Lew .
In summary, during the past 3 months, insiders sold 26,408 shares of Annexon Inc (ANNX) in total and bought 6,400 shares, with a net sale of 20,008 shares. During the past 18 months, 92,392 shares of Annexon Inc (ANNX) were sold and 672,400 shares were bought by its insiders, resulting in a net purchase of 580,008 shares.
Annexon Inc (ANNX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Annexon Inc Insider Transactions
- Download to Excel(.xls)
What does Nkarta Inc do?
Who are the key executives at Nkarta Inc?
Nea Partners 15, L.p. is the 10 percent owner of Nkarta Inc. Other key executives at Nkarta Inc include Chief Legal Officer Alicia J. Hager , Chief Medical Officer David Shook , and Sr. VP & Technical Operations Ralph Brandenberger .
Nkarta Inc (NKTX) Insider Trades Summary
Over the past 18 months, Nea Partners 15, L.p. made no insider transaction in Nkarta Inc (NKTX). Other recent insider transactions involving Nkarta Inc (NKTX) include a net sale of 9,598 shares made by James Trager , a net sale of 9,378 shares made by Alicia J. Hager , and a net sale of 5,778 shares made by David Shook .
In summary, during the past 3 months, insiders sold 0 shares of Nkarta Inc (NKTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 41,413 shares of Nkarta Inc (NKTX) were sold and 5,000,000 shares were bought by its insiders, resulting in a net purchase of 4,958,587 shares.
Nkarta Inc (NKTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Nkarta Inc Insider Transactions
- Download to Excel(.xls)
What does AVEO Pharmaceuticals Inc do?
Who are the key executives at AVEO Pharmaceuticals Inc?
Nea Partners 15, L.p. is the 10 percent owner of AVEO Pharmaceuticals Inc. Other key executives at AVEO Pharmaceuticals Inc include Chief Operating Officer Jebediah Ledell , director & President & CEO Michael P Bailey , and Chief Commercial Officer Michael Ferraresso .
AVEO Pharmaceuticals Inc (AVEO) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of AVEO Pharmaceuticals Inc (AVEO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of AVEO Pharmaceuticals Inc (AVEO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
AVEO Pharmaceuticals Inc (AVEO)'s detailed insider trading history can be found in Insider Trading Tracker table.
AVEO Pharmaceuticals Inc Insider Transactions
- Download to Excel(.xls)
What does Nightstar Therapeutics PLC do?
Who are the key executives at Nightstar Therapeutics PLC?
Nea Partners 15, L.p. is the 10 percent owner of Nightstar Therapeutics PLC. Other key executives at Nightstar Therapeutics PLC include 10 percent owner Scott D Sandell , 10 percent owner Peter J Barris , and director & 10 percent owner David M Mott .
Nightstar Therapeutics PLC (NITE) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Nightstar Therapeutics PLC (NITE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Nightstar Therapeutics PLC (NITE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Nightstar Therapeutics PLC (NITE)'s detailed insider trading history can be found in Insider Trading Tracker table.
Nightstar Therapeutics PLC Insider Transactions
- Download to Excel(.xls)
What does Millendo Therapeutics Inc do?
Who are the key executives at Millendo Therapeutics Inc?
Nea Partners 15, L.p. is the 10 percent owner of Millendo Therapeutics Inc. Other key executives at Millendo Therapeutics Inc include General Counsel and Secretary Tamara L Joseph , Chief Financial Officer Arcudi Iii Louis J , and director & President and CEO Julia C. Owens .
Millendo Therapeutics Inc (MLND) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Millendo Therapeutics Inc (MLND) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Millendo Therapeutics Inc (MLND) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Millendo Therapeutics Inc (MLND)'s detailed insider trading history can be found in Insider Trading Tracker table.
Millendo Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does Cascadian Therapeutics Inc do?
Who are the key executives at Cascadian Therapeutics Inc?
Nea Partners 15, L.p. is the 10 percent owner of Cascadian Therapeutics Inc. Other key executives at Cascadian Therapeutics Inc include 10 percent owner Nea 15 Gp, Llc , 10 percent owner Florence Anthony A. Jr. , and 10 percent owner Peter W. Sonsini .
Cascadian Therapeutics Inc (CASC) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Cascadian Therapeutics Inc (CASC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Cascadian Therapeutics Inc (CASC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Cascadian Therapeutics Inc (CASC)'s detailed insider trading history can be found in Insider Trading Tracker table.
Cascadian Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does ARCA biopharma Inc do?
Who are the key executives at ARCA biopharma Inc?
Nea Partners 15, L.p. is the 10 percent owner of ARCA biopharma Inc. Other key executives at ARCA biopharma Inc include 10 percent owner & other: See Footnote 1 Funicular Funds, Lp , other: See Footnote 1 Funicular Fund, Lp , and other: See Remarks Jacob Ma-weaver .
ARCA biopharma Inc (ABIO) Insider Trades Summary
Over the past 18 months, Nea Partners 15, L.p. made no insider transaction in ARCA biopharma Inc (ABIO). Other recent insider transactions involving ARCA biopharma Inc (ABIO) include a net purchase of 634,678 shares made by ,
In summary, during the past 3 months, insiders sold 0 shares of ARCA biopharma Inc (ABIO) in total and bought 485 shares, with a net purchase of 485 shares. During the past 18 months, 0 shares of ARCA biopharma Inc (ABIO) were sold and 52,890 shares were bought by its insiders, resulting in a net purchase of 52,890 shares.
ARCA biopharma Inc (ABIO)'s detailed insider trading history can be found in Insider Trading Tracker table.
ARCA biopharma Inc Insider Transactions
- Download to Excel(.xls)
What does Achaogen Inc do?
Who are the key executives at Achaogen Inc?
Nea Partners 15, L.p. is the 10 percent owner of Achaogen Inc. Other key executives at Achaogen Inc include 10 percent owner Robert W Duggan , Chief Operating Officer Elizabeth Bhatt , and See Remarks Gary Loeb .
Achaogen Inc (AKAOQ) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Achaogen Inc (AKAOQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Achaogen Inc (AKAOQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Achaogen Inc (AKAOQ)'s detailed insider trading history can be found in Insider Trading Tracker table.
Achaogen Inc Insider Transactions
- Download to Excel(.xls)
What does Tempest Therapeutics Inc do?
Who are the key executives at Tempest Therapeutics Inc?
Nea Partners 15, L.p. is the 10 percent owner of Tempest Therapeutics Inc. Other key executives at Tempest Therapeutics Inc include 10 percent owner Versant Venture Capital Vi, L.p. , director & Chief Executive Officer Stephen R Brady , and Chief Medical Officer Samuel Whiting .
Tempest Therapeutics Inc (TPST) Insider Trades Summary
Over the past 18 months, Nea Partners 15, L.p. made no insider transaction in Tempest Therapeutics Inc (TPST). Other recent insider transactions involving Tempest Therapeutics Inc (TPST) include a net sale of 787,999 shares made by Versant Venture Capital Vi, L.p. , a net purchase of 35,000 shares made by Stephen R Brady , and a net purchase of 4,672 shares made by Samuel Whiting .
In summary, during the past 3 months, insiders sold 787,999 shares of Tempest Therapeutics Inc (TPST) in total and bought 0 shares, with a net sale of 787,999 shares. During the past 18 months, 787,999 shares of Tempest Therapeutics Inc (TPST) were sold and 39,672 shares were bought by its insiders, resulting in a net sale of 748,327 shares.
Tempest Therapeutics Inc (TPST)'s detailed insider trading history can be found in Insider Trading Tracker table.
Tempest Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does Reneo Pharmaceuticals Inc do?
Who are the key executives at Reneo Pharmaceuticals Inc?
Nea Partners 15, L.p. is the 10 percent owner of Reneo Pharmaceuticals Inc. Other key executives at Reneo Pharmaceuticals Inc include Chief Development Officer Ashley Hall , 10 percent owner Novo Holdings A/s , and Senior VP & Corporate Operation Michael Cruse .
Reneo Pharmaceuticals Inc (RPHM) Insider Trades Summary
Over the past 18 months, Nea Partners 15, L.p. made no insider transaction in Reneo Pharmaceuticals Inc (RPHM). Other recent insider transactions involving Reneo Pharmaceuticals Inc (RPHM) include a net purchase of 1,199,482 shares made by Braden Michael Leonard , a net purchase of 125,000 shares made by Niall O'donnell , and a net sale of 100,000 shares made by Novo Holdings A/s .
In summary, during the past 3 months, insiders sold 0 shares of Reneo Pharmaceuticals Inc (RPHM) in total and bought 78,520 shares, with a net purchase of 78,520 shares. During the past 18 months, 11,563 shares of Reneo Pharmaceuticals Inc (RPHM) were sold and 132,448 shares were bought by its insiders, resulting in a net purchase of 120,886 shares.
Reneo Pharmaceuticals Inc (RPHM)'s detailed insider trading history can be found in Insider Trading Tracker table.
Reneo Pharmaceuticals Inc Insider Transactions
- Download to Excel(.xls)
What does NeueHealth Inc do?
Who are the key executives at NeueHealth Inc?
Nea Partners 15, L.p. is the 10 percent owner of NeueHealth Inc. Other key executives at NeueHealth Inc include Chief Financial Officer Jay Matushak , Chief Accounting Officer Jeffrey J Scherman , and director & CEO and President Mikan George Lawrence Iii .
NeueHealth Inc (NEUE) Insider Trades Summary
Over the past 18 months, Nea Partners 15, L.p. made no insider transaction in NeueHealth Inc (NEUE). Other recent insider transactions involving NeueHealth Inc (NEUE) include a net sale of 3,494 shares made by Jay Matushak , a net sale of 7,272 shares made by Jeffrey J Scherman , and a net sale of 56,739 shares made by Mikan George Lawrence Iii .
In summary, during the past 3 months, insiders sold 87 shares of NeueHealth Inc (NEUE) in total and bought 0 shares, with a net sale of 87 shares. During the past 18 months, 65,823 shares of NeueHealth Inc (NEUE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 65,823 shares.
NeueHealth Inc (NEUE)'s detailed insider trading history can be found in Insider Trading Tracker table.
NeueHealth Inc Insider Transactions
- Download to Excel(.xls)
What does Desktop Metal Inc do?
Who are the key executives at Desktop Metal Inc?
Nea Partners 15, L.p. is the 10 percent owner of Desktop Metal Inc. Other key executives at Desktop Metal Inc include CHIEF OPERATING OFFICER Thomas Nogueira , CFO & TREASURER Jason M Cole , and Chief Technology Officer Jonah Myerberg .
Desktop Metal Inc (DM) Insider Trades Summary
Over the past 18 months, Nea Partners 15, L.p. made no insider transaction in Desktop Metal Inc (DM). Other recent insider transactions involving Desktop Metal Inc (DM) include a net sale of 384,064 shares made by Jason M Cole , a net sale of 190,004 shares made by Jonah Myerberg , and a net sale of 7,298 shares made by Thomas Nogueira .
In summary, during the past 3 months, insiders sold 7,298 shares of Desktop Metal Inc (DM) in total and bought 0 shares, with a net sale of 7,298 shares. During the past 18 months, 86,362 shares of Desktop Metal Inc (DM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 86,362 shares.
Desktop Metal Inc (DM)'s detailed insider trading history can be found in Insider Trading Tracker table.
Desktop Metal Inc Insider Transactions
- Download to Excel(.xls)
What does Robinhood Markets Inc do?
Who are the key executives at Robinhood Markets Inc?
Nea Partners 15, L.p. is the director & 10 percent owner of Robinhood Markets Inc. Other key executives at Robinhood Markets Inc include director & 10 percent owner & Chief Creative Officer Baiju Bhatt , Chief Brokerage Officer Steven M. Quirk , and director & 10 percent owner & Chief Executive Officer Vladimir Tenev .
Robinhood Markets Inc (HOOD) Insider Trades Summary
Over the past 18 months, Nea Partners 15, L.p. made no insider transaction in Robinhood Markets Inc (HOOD). Other recent insider transactions involving Robinhood Markets Inc (HOOD) include a net sale of 3,094,117 shares made by Baiju Bhatt , a net sale of 4,354,068 shares made by Vladimir Tenev , and a net sale of 276,641 shares made by Gallagher Daniel Martin Jr .
In summary, during the past 3 months, insiders sold 4,389,654 shares of Robinhood Markets Inc (HOOD) in total and bought 0 shares, with a net sale of 4,389,654 shares. During the past 18 months, 11,339,818 shares of Robinhood Markets Inc (HOOD) were sold and 0 shares were bought by its insiders, resulting in a net sale of 11,339,818 shares.
Robinhood Markets Inc (HOOD)'s detailed insider trading history can be found in Insider Trading Tracker table.
Robinhood Markets Inc Insider Transactions
- Download to Excel(.xls)
What does Arcellx Inc do?
Who are the key executives at Arcellx Inc?
Nea Partners 15, L.p. is the 10 percent owner of Arcellx Inc. Other key executives at Arcellx Inc include Chief Financial Officer Michelle Gilson , Chief Medical Officer Christopher Heery , and director & See Remarks Rami Elghandour .
Arcellx Inc (ACLX) Insider Trades Summary
Over the past 18 months, Nea Partners 15, L.p. made no insider transaction in Arcellx Inc (ACLX). Other recent insider transactions involving Arcellx Inc (ACLX) include a net sale of 345,747 shares made by Christopher Heery , a net sale of 19,000 shares made by Kavita Patel , and a net sale of 70,041 shares made by Michelle Gilson .
In summary, during the past 3 months, insiders sold 79,006 shares of Arcellx Inc (ACLX) in total and bought 0 shares, with a net sale of 79,006 shares. During the past 18 months, 3,546,510 shares of Arcellx Inc (ACLX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 3,546,510 shares.
Arcellx Inc (ACLX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Arcellx Inc Insider Transactions
- Download to Excel(.xls)
What does Berkshire Grey Inc do?
Who are the key executives at Berkshire Grey Inc?
Nea Partners 15, L.p. is the 10 percent owner of Berkshire Grey Inc. Other key executives at Berkshire Grey Inc include 10 percent owner Svf Ii Bg (de) Llc , 10 percent owner Softbank Group Corp , and director & Chief Executive Officer Thomas Anderson Wagner .
Berkshire Grey Inc (BGRY) Insider Trades Summary
Over the past 18 months, Nea Partners 15, L.p. made no insider transaction in Berkshire Grey Inc (BGRY). Other recent insider transactions involving Berkshire Grey Inc (BGRY) include a net sale of 65,567,317 shares made by Svf Ii Bg (de) Llc ,
In summary, during the past 3 months, insiders sold 0 shares of Berkshire Grey Inc (BGRY) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 65,567,317 shares of Berkshire Grey Inc (BGRY) were sold and 0 shares were bought by its insiders, resulting in a net sale of 65,567,317 shares.
Berkshire Grey Inc (BGRY)'s detailed insider trading history can be found in Insider Trading Tracker table.
Berkshire Grey Inc Insider Transactions
- Download to Excel(.xls)
What does IonQ Inc do?
Who are the key executives at IonQ Inc?
Nea Partners 15, L.p. is the 10 percent owner of IonQ Inc. Other key executives at IonQ Inc include Chief Revenue Officer Rima Alameddine , director & President and CEO Peter Hume Chapman , and Chief Financial Officer Thomas G. Kramer .
IonQ Inc (IONQ) Insider Trades Summary
Over the past 18 months, Nea Partners 15, L.p. made no insider transaction in IonQ Inc (IONQ). Other recent insider transactions involving IonQ Inc (IONQ) include a net sale of 205,648 shares made by Rima Alameddine , a net sale of 71,110 shares made by Thomas G. Kramer , and a net sale of 121,094 shares made by Peter Hume Chapman .
In summary, during the past 3 months, insiders sold 104,804 shares of IonQ Inc (IONQ) in total and bought 0 shares, with a net sale of 104,804 shares. During the past 18 months, 847,605 shares of IonQ Inc (IONQ) were sold and 115,005 shares were bought by its insiders, resulting in a net sale of 732,600 shares.
IonQ Inc (IONQ)'s detailed insider trading history can be found in Insider Trading Tracker table.
IonQ Inc Insider Transactions
- Download to Excel(.xls)
What does Senti Biosciences Inc do?
Who are the key executives at Senti Biosciences Inc?
Nea Partners 15, L.p. is the 10 percent owner of Senti Biosciences Inc. Other key executives at Senti Biosciences Inc include Chief Medical & Devt. Officer Kanya Rajangam , Chief Operating Officer Herberts Curt A. Iii , and 10 percent owner Bayer Us Holding Lp .
Senti Biosciences Inc (SNTI) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Senti Biosciences Inc (SNTI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Senti Biosciences Inc (SNTI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Senti Biosciences Inc (SNTI)'s detailed insider trading history can be found in Insider Trading Tracker table.
Senti Biosciences Inc Insider Transactions
- Download to Excel(.xls)
What does Revolution Acceleration Acquisition Corp do?
Who are the key executives at Revolution Acceleration Acquisition Corp?
Nea Partners 15, L.p. is the 10 percent owner of Revolution Acceleration Acquisition Corp. Other key executives at Revolution Acceleration Acquisition Corp include 10 percent owner Softbank Group Corp , director & Chief Executive Officer Thomas Anderson Wagner , and See Remarks Steven Jay Johnson .
Revolution Acceleration Acquisition Corp (RAACU) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Revolution Acceleration Acquisition Corp (RAACU) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Revolution Acceleration Acquisition Corp (RAACU) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Revolution Acceleration Acquisition Corp (RAACU)'s detailed insider trading history can be found in Insider Trading Tracker table.
Revolution Acceleration Acquisition Corp Insider Transactions
- Download to Excel(.xls)
Nea Partners 15, L.p. Mailing Address
Above is the net worth, insider trading, and ownership report for Nea Partners 15, L.p.. You might contact Nea Partners 15, L.p. via mailing address: 1954 Greenspring Drive, Suite 600, Timonium Md 21093.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
